Lv01
0 积分 2023-12-12 加入
Targeting SALL4 with an HLA Class I–restricted TCR for cancer immunotherapy
1小时前
已完结
Preclinical studies show that Co-STARs combine the advantages of chimeric antigen and T cell receptors for the treatment of tumors with low antigen densities
5个月前
已完结
Preclinical studies show that Co-STARs combine the advantages of chimeric antigen and T cell receptors for the treatment of tumors with low antigen densities
5个月前
已完结
Optimized PEI‐based Transfection Method for Transient Transfection and Lentiviral Production
1年前
已完结
NK Receptor Signaling Lowers TCR Activation Threshold, Enhancing Selective Recognition of Cancer Cells by TAA-Specific CTLs
1年前
已完结
Dual-receptor T cell platform with Ab-TCR and costimulatory receptor achieves specificity and potency against AML
1年前
已完结
皖公网安备34019202002308
